Elbadawy HM - Search Results

1

Introducing of acyclonucleoside analogues tethered 1,2,4-triazole as anticancer agents with dual epidermal growth factor receptor kinase and microtubule inhibitors.

Aouad MR, Al-Mohammadi HM, Al-Blewi FF, Ihmaid S, Elbadawy HM, Althagfan SS, Rezki N. Aouad MR, et al. Among authors: elbadawy hm. Bioorg Chem. 2020 Jan;94:103446. doi: 10.1016/j.bioorg.2019.103446. Epub 2019 Nov 23. Bioorg Chem. 2020. PMID: 31791685

2

Enhancement of atorvastatin oral bioavailability via encapsulation in polymeric nanoparticles.

Shaker MA, Elbadawy HM, Al Thagfan SS, Shaker MA. Shaker MA, et al. Among authors: elbadawy hm. Int J Pharm. 2021 Jan 5;592:120077. doi: 10.1016/j.ijpharm.2020.120077. Epub 2020 Nov 24. Int J Pharm. 2021. PMID: 33246047

3

Design of molecular hybrids of phthalimide-triazole agents with potent selective MCF-7/HepG2 cytotoxicity: Synthesis, EGFR inhibitory effect, and metabolic stability.

Ihmaid SK, Alraqa SY, Aouad MR, Aljuhani A, Elbadawy HM, Salama SA, Rezki N, Ahmed HEA. Ihmaid SK, et al. Among authors: elbadawy hm. Bioorg Chem. 2021 Jun;111:104835. doi: 10.1016/j.bioorg.2021.104835. Epub 2021 Mar 22. Bioorg Chem. 2021. PMID: 33798850

4

Improved solubility, dissolution, and oral bioavailability for atorvastatin-Pluronic® solid dispersions.

Shaker MA, Elbadawy HM, Shaker MA. Shaker MA, et al. Among authors: elbadawy hm. Int J Pharm. 2020 Jan 25;574:118891. doi: 10.1016/j.ijpharm.2019.118891. Epub 2019 Nov 28. Int J Pharm. 2020. PMID: 31786357

5

Generation of Combinatorial Lentiviral Vectors Expressing Multiple Anti-Hepatitis C Virus shRNAs and Their Validation on a Novel HCV Replicon Double Reporter Cell Line.

Elbadawy HM, Mohammed Abdul MI, Aljuhani N, Vitiello A, Ciccarese F, Shaker MA, Eltahir HM, Palù G, Di Antonio V, Ghassabian H, Del Vecchio C, Salata C, Franchin E, Ponterio E, Bahashwan S, Thabet K, Abouzied MM, Shehata AM, Parolin C, Calistri A, Alvisi G. Elbadawy HM, et al. Viruses. 2020 Sep 18;12(9):1044. doi: 10.3390/v12091044. Viruses. 2020. PMID: 32962117 Free PMC article.

6

Incremental Concentrations of Tacrolimus Eye Drops as a Strategy for the Management of Severe Vernal Keratoconjunctivitis.

Albarry MA, Parekh M, Ferrari S, Eltahir HM, Shehata AM, Shaker MA, Elbadawy HM. Albarry MA, et al. Among authors: elbadawy hm. Front Pharmacol. 2022 Mar 25;13:798998. doi: 10.3389/fphar.2022.798998. eCollection 2022. Front Pharmacol. 2022. PMID: 35401178 Free PMC article.

7

Targeting herpetic keratitis by gene therapy.

Elbadawy HM, Gailledrat M, Desseaux C, Ponzin D, Ferrari S. Elbadawy HM, et al. J Ophthalmol. 2012;2012:594869. doi: 10.1155/2012/594869. Epub 2012 Dec 26. J Ophthalmol. 2012. PMID: 23326647 Free PMC article.

8

Gene transfer of integration defective anti-HSV-1 meganuclease to human corneas ex vivo.

Elbadawy HM, Gailledrat M, Desseaux C, Salvalaio G, Di Iorio E, Ferrari B, Bertolin M, Barbaro V, Parekh M, Gayon R, Munegato D, Franchin E, Calistri A, Palù G, Parolin C, Ponzin D, Ferrari S. Elbadawy HM, et al. Gene Ther. 2014 Mar;21(3):272-81. doi: 10.1038/gt.2013.82. Epub 2014 Jan 16. Gene Ther. 2014. PMID: 24430237

9

A superfusion apparatus for ex vivo human eye irritation investigations.

Elbadawy HM, Salvalaio G, Parekh M, Ruzza A, Baruzzo M, Cagini C, Ponzin D, Ferrari S. Elbadawy HM, et al. Toxicol In Vitro. 2015 Oct;29(7):1619-27. doi: 10.1016/j.tiv.2015.06.022. Epub 2015 Jun 20. Toxicol In Vitro. 2015. PMID: 26100225

10

Transplantation failure due to inadvertent reversal of human donor corneas.

Parekh M, Ruzza A, Elbadawy H, Ferrari S, Salvalaio G, Camposampiero D, Ponzin D. Parekh M, et al. Eur J Ophthalmol. 2016 Feb 15;26(2):e21-3. doi: 10.5301/ejo.5000711. Eur J Ophthalmol. 2016. PMID: 26659020

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

35 results

Search Page